Most sold healthcare stocks in Q2 2018
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2018, measured as net reductions in reported share positions from Q1 2018 into Q2 2018. Notable reductions at the top of this list include MERCK & CO. INC. (MRK), DENTSPLY SIRONA INC (XRAY), NOVARTIS AG-SPONSORED ADR (NVS), CARDINAL HEALTH INC (CAH). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| MRK | MERCK & CO. INC. | -9,970,626 | -$444.89M | 1 | 4 | 5 | 0 | 12 |
| XRAY | DENTSPLY SIRONA INC | -7,856,877 | -$418.12M | 1 | 1 | 3 | 0 | 6 |
| NVS | NOVARTIS AG-SPONSORED ADR | -4,960,270 | -$664.50M | 0 | 2 | 5 | 1 | 8 |
| CAH | CARDINAL HEALTH INC | -4,808,839 | -$426.64M | 0 | 3 | 1 | 1 | 5 |
| PDCO | PATTERSON COS INC | -3,164,883 | -$69.76M | 0 | 0 | 1 | 2 | 2 |
| DHR | DANAHER CORP | -2,120,148 | -$196.01M | 0 | 1 | 4 | 0 | 10 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,755,370 | -$54.00M | 0 | 0 | 1 | 0 | 2 |
| OMI | OWENS & MINOR INC | -1,474,535 | -$22.93M | 0 | 0 | 0 | 1 | 0 |
| BSX | BOSTON SCIENTIFIC CORP | -1,409,505 | -$23.42M | 0 | 0 | 3 | 0 | 4 |
| ELV | ELEVANCE HEALTH INC | -1,339,224 | -$129.92M | 1 | 2 | 2 | 1 | 8 |
| EXAS | EXACT SCIENCES CORP | -1,298,001 | -$52.35M | 0 | 0 | 0 | 1 | 0 |
| NKTR | NEKTAR THERAPEUTICS | -1,192,300 | -$126.69M | 0 | 0 | 0 | 1 | 0 |
| GRFS | GRIFOLS SA-ADR | -889,997 | -$15.64M | 0 | 0 | 1 | 0 | 2 |
| HALO | HALOZYME THERAPEUTICS INC | -881,678 | -$23.61M | 0 | 0 | 2 | 0 | 4 |
| VREX | VAREX IMAGING CORP | -769,602 | -$26.24M | 0 | 0 | 1 | 0 | 2 |
| SYK | STRYKER CORP | -705,515 | -$49.62M | 0 | 1 | 4 | 0 | 5 |
| UNH | UNITEDHEALTH GROUP INC | -647,380 | $601.20M | 0 | 3 | 11 | 0 | 17 |
| ABT | ABBOTT LABORATORIES | -411,852 | -$20.38M | 0 | 2 | 3 | 0 | 6 |
| CVS | CVS HEALTH CORP | -376,603 | $34.87M | 0 | 4 | 2 | 1 | 8 |
| BAX | BAXTER INTERNATIONAL INC | -367,313 | $300.52M | 0 | 0 | 2 | 1 | 6 |
| PRGO | Perrigo Company PLC | -347,700 | -$71.77M | 0 | 1 | 1 | 0 | 3 |
| ALGN | ALIGN TECHNOLOGY INC | -336,815 | $216.73M | 0 | 0 | 4 | 0 | 6 |
| CUE | CUE BIOPHARMA INC | -305,000 | -$4.71M | 0 | 0 | 1 | 0 | 1 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | -283,989 | -$3.13M | 0 | 0 | 1 | 0 | 1 |
| EGRX | EAGLE PHARMACEUTICALS INC | -274,589 | -$9.27M | 0 | 0 | 1 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | -154,451 | $124.47M | 0 | 2 | 6 | 0 | 10 |
| IONS | IONIS PHARMACEUTICALS INC | -138,778 | -$6.63M | 0 | 0 | 1 | 0 | 2 |
| SNY | SANOFI-ADR | -134,383 | -$9.98M | 0 | 1 | 1 | 0 | 5 |
| INCY | INCYTE CORP | -126,756 | -$11.28M | 0 | 1 | 0 | 1 | 2 |
| TECH | BIO-TECHNE CORP | -86,670 | -$17.08M | 0 | 0 | 1 | 0 | 2 |
| INVA | INNOVIVA INC | -70,063 | -$4.88M | 0 | 0 | 1 | 0 | 2 |
| CRL | CHARLES RIVER LABORATORIES | -41,466 | $2.86M | 1 | 0 | 1 | 0 | 3 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | -37,590 | -$6.53M | 0 | 0 | 1 | 0 | 1 |
| HSIC | HENRY SCHEIN INC | -37,160 | -$2.25M | 0 | 0 | 1 | 0 | 1 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | -29,890 | -$99.89M | 0 | 1 | 1 | 0 | 3 |
| AMN | AMN HEALTHCARE SERVICES INC | -29,200 | -$1.46M | 0 | 2 | 1 | 0 | 3 |
| MYGN | MYRIAD GENETICS INC | -19,646 | $9.60M | 0 | 0 | 1 | 0 | 2 |
| BIO | BIO-RAD LABORATORIES-A | -19,153 | $4.13M | 0 | 0 | 1 | 0 | 2 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -18,854 | $21.00K | 1 | 0 | 1 | 0 | 3 |
| LFCR | LIFECORE BIOMEDICAL INC | -18,262 | $359.00K | 0 | 0 | 1 | 0 | 1 |
| ISRG | INTUITIVE SURGICAL INC | -17,000 | $18.47M | 1 | 0 | 1 | 0 | 5 |
| PINC | PREMIER INC-CLASS A | -12,387 | $1.08M | 0 | 1 | 1 | 0 | 2 |
| ABBV | ABBVIE INC | -2,575 | -$1.39M | 0 | 4 | 3 | 0 | 11 |
| OMCL | OMNICELL INC | -1,668 | $114.00K | 0 | 0 | 1 | 0 | 1 |
| WST | WEST PHARMACEUTICAL SERVICES | -1,334 | $182.00K | 0 | 0 | 1 | 0 | 2 |
| CARA | CARA THERAPEUTICS INC | -1,278 | $5.79M | 0 | 0 | 1 | 0 | 1 |
| MDXG | MIMEDX GROUP INC | -996 | -$421.00K | 0 | 0 | 1 | 0 | 1 |
| SRDX | SURMODICS INC | -367 | $3.03M | 0 | 0 | 1 | 0 | 2 |
| MOH | MOLINA HEALTHCARE INC | -115 | $41.00K | 0 | 0 | 1 | 0 | 2 |
| NEOG | NEOGEN CORP | -103 | $118.00K | 0 | 1 | 1 | 0 | 3 |
Frequently asked questions about Most sold healthcare stocks in Q2 2018
What are the most sold Healthcare stocks in Q2 2018?
The most sold healthcare stocks in Q2 2018 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2018?
Among filers in this sector, net reductions were largest in companies such as MERCK & CO. INC. (MRK), DENTSPLY SIRONA INC (XRAY), NOVARTIS AG-SPONSORED ADR (NVS), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.